1523-4681/asset/olbannerleft.gif?v=1&s=d7e4c0e37904a489128d3a4e58ba94214db307a9)
1523-4681/asset/olbannerright.gif?v=1&s=854ee0e4d351ead9faaca8bfab3e50b1c7c9d03d)
Original Article
You have full text access to this OnlineOpen article
Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes
Article first published online: 19 AUG 2011
DOI: 10.1002/jbmr.424
Copyright © 2011 American Society for Bone and Mineral Research
Additional Information
How to Cite
Gharibi, B., Abraham, A. A., Ham, J. and Evans, B. A. (2011), Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes. J Bone Miner Res, 26: 2112–2124. doi: 10.1002/jbmr.424
Publication History
- Issue published online: 19 AUG 2011
- Article first published online: 19 AUG 2011
- Accepted manuscript online: 16 MAY 2011 11:13AM EST
- Manuscript Accepted: 4 MAY 2011
- Manuscript Revised: 31 MAR 2011
- Manuscript Received: 28 OCT 2010
References
- 1, . Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheum. 2006; 2: 35–43.
- 2, . Bone: adiposity and bone accrual—still an established paradigm? Nat Rev Endocrinol. 2010; 6: 63–64.
- 3, , . Mesenchymal stem cells. Exp Biol Med. 2001; 226: 507–520.
- 4, , . Mechanisms balancing skeletal matrix synthesis and degradation. Biochem J. 2002; 364: 329–341.
- 5, . Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006; 98: 1076–1084.
- 6, , , . Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front Biosci. 2007; 12: 3068–3092.
- 7, . Adipose Development: From Stem Cell to Adipocyte. Crit Rev Biochem Mol. 2005; 40: 229–242.
- 8, , , . Reciprocal Relation between Marrow Adiposity and the Amount of Bone in the Axial and Appendicular Skeleton of Young Adults. J Clin Endocrinol Metab. 2008; 93: 2281–2286.
- 9, , , , , . Bone Acquisition in Healthy Young Females Is Reciprocally Related to Marrow Adiposity. J Clin Endocrinol Metab. 2010; 95: 2977–2982.
- 10, , , , . Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J Clin Pathol. 2002; 55: 693–698.
- 11, , , , , . Patients With High Bone Mass Phenotype Exhibit Enhanced Osteoblast Differentiation and Inhibition of Adipogenesis of Human Mesenchymal Stem Cells. J Bone Miner Res. 2007; 22: 1720–1731.
- 12, , , et al. Mechanical Loading Down-Regulates Peroxisome Proliferator-Activated Receptor g in Bone Marrow Stromal Cells and Favors Osteoblastogenesis at the Expense of Adipogenesis. Endocrinology. 2007; 148: 2553–2562.
- 13. Adenosine receptors as drug targets. Exp Cell Res. 2010; 316: 1284–1288.
- 14, , , et al. Human Osteoblast Precursors Produce Extracellular Adenosine, Which Modulates Their Secretion of IL-6 and Osteoprotegerin. J Bone Miner Res. 2006; 21: 228–236.
- 15, , , et al. Wound healing is accelerated by agonists of adenosine A(2) (G(alphas)-linked) receptors. J Exp Med. 1997; 186: 1615–1620.
- 16. Molecular approach to adenosine receptors: Receptor-Mediated Mechanisms of Tissue Protection. Ann Rev Pharmacol. 2001; 41: 775–787.
- 17, . Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature. 2001; 414: 916–920.
- 18, , , et al. Adenosine Promotes Wound Healing and Mediates Angiogenesis in Response to Tissue Injury Via Occupancy of A2A Receptors. Am J Pathol. 2002; 160: 2009–2018.
- 19, , . Adenosine A2A receptors play an active role in mouse bone marrow-derived mesenchymal stem cell development. J Leukocyte Biol. 2009; 85: 438–444.
- 20, , , , . Differential Expression of Adenosine-A1 and Adenosine-A2 Receptors in Preadipocytes and Adipocytes. Biochem Biophysl Res Co. 1993; 193: 1123–1130.
- 21, , , et al. Changes in adenosine A1- and A2-receptor expression during adipose cell differentiation. Mol Cell Endocrinol. 1996; 117: 17–25.
- 22, , . A1 Adenosine Receptor Activation Increases Adipocyte Leptin Secretion. Endocrinology. 2000; 141: 1442–1445.
- 23, , . Overexpression of the A1 adenosine receptor in adipose tissue protects mice from obesity-related insulin resistance. Diabetes Obes Metab. 2001; 3: 360–366.
- 24, , , et al. Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous. J Cell Biochem. 2001; 81: 312–319.
- 25, , , , , . Complex regulation of nucleoside transporter expression in epithelial and immune system cells. Mol Membr Biol. 2001; 18: 81–85.
- 26, , , . The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol. 2001; 18: 53–63.
- 27, . Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem. 2001; 79: 463–484.
- 28, , , et al. Biochemical and biophysical analyses of tissue-engineered bone obtained from three-dimensional culture of a subset of bone marrow mesenchymal stem cells. Tissue Eng Part A. 2010; 16: 3657–3667.
- 29, , , , , . Adenosine inhibits chemotaxis and induces hepatocyte-specific genes in bone marrow mesenchymal stem cells. Hepatology. 2010; 51: 963–973.
- 30, , , . Adenosine Inhibition of Lipopolysaccharide-Induced Interleukin-6 Secretion by the Osteoblastic Cell Line MG-63. Calcif Tissue Int. 2007; 81: 316–326.
- 31, , . Hydrogen peroxide-induced oxidative stress in MC3T3-E1cells: The effects of glutamate and protection by purines. Bone. 2006; 39: 542–551.
- 32, , , , . Identifying a molecular phenotype for bone marrow stromal cells with in vivo bone-forming capacity. J Bone Miner Res. 2010; 25: 796–808.
- 33, , , et al. A Novel Partial Agonist of the A1 -Adenosine Receptor and Evidence of Receptor Homogeneity in Adipocytes. J Pharmacol Exp Ther. 2006; 317: 676–684.
- 34
- 35, , , . Pharmacology and Therapeutic Applications of A1 Adenosine Receptor Ligands. Curr Top Med Chem. 2003; 3: 369–385.
- 36, , , , , . Antilipolytic Activity of a Novel Partial A1 Adenosine Receptor Agonist Devoid of Cardiovascular Effects: Comparison with Nicotinic Acid. J Pharmacol Exp Ther. 2007; 321: 327–333.
- 37, , , , . Differences in the Expression of the Adenosine A1 Receptor in Adipose Tissue of Obese Black and White Women. J Clin Endocrinol Metab. 2006; 91: 1882–1886.
- 38, , , , , , , . Cyclic AMP (cAMP)-mediated stimulation of adipocyte differentiation requires the synergistic action of Epac- and cAMP-dependent protein kinase-dependent processes. Mol Cell Biol. 2008; 28: 3804–3816.
- 39, , , , , , . cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin. PLoS One. 2008; 3: e1540.
- 40, , , . Role of CREB in transcriptional regulation of CCAAT/enhancer-binding protein b gene during adipogenesis. J Biol Chem. 2004; 279: 4471–4478.
- 41, , , , , . Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1cells ectopically expressing CCAAT/enhancer-binding protein (C/EBP) alpha, C/EBP beta, or PPAR gamma2. J Biol Chem. 2006; 281: 40341–40353.
- 42, , . Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: Cross talk with the osteoblastogenic program. Cell Mol Life Sci. 2009; 66: 236–253.
- 43, , , et al. A large-conductance (BK) potassium channel subtype affects both growth and mineralization of human osteoblasts. Am J Physiol Cell Physiol. 2009; 97: C1397–1408.